Home Bionik Laboratories

Bionik Laboratories

Landmark Robot Assisted Training for the RATULS Trial Completed

The RATULS trial confirmed the finding of previous research studies which demonstrated that robot-assisted therapy improved upper limb impairment when compared with conventional care methods for stroke victims.

Next-Generation InMotion ARM/HAND Robotic System to Improve Rehabilitation for Stroke Survivors is Launched by BIONIK

1/23/19: InMotion ARM/HAND™ robotic system was developed according to the same principals of motor learning and neuro-plasticity that were incorporated into the original InMotion ARM robotic system, and utilizes artificial intelligence and data analysis to provide individualized therapy and reports that empower patients.

BIONIK Laboratories Announces Purchase Agreement from Clinique Les Trois Soleils for InMotion Arm™ Robotic System

10/24/18: The purchase order is for one of BIONIK's improved InMotion Arm™ robotic systems, whose launch was announced this year and recently received a "CE marking" from the European Commission.

Bionik Laboratories and Wistron Corporation Partner to Develop Exoskeleton Technologies for Consumer Medical Device Market

Bionik Laboratories Corp. (OTCQX:BNKL) (a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital...

Must Read

New Study Validates Rigorous Safety Measures Needed To Reduce Mercury Exposure During Dental Amalgam Filling Removal

"For decades, our non-profit organization has been concerned about this issue and collected research about amalgam fillings, all of which contain approximately 50% mercury, a known neurotoxin," explains IAOMT President Michael Rehme, DDS, NMD.  "Based on this science, we have strongly recommended that safety measures be enacted for dental procedures involving these silver-colored fillings, and we have also intensely advocated for the end of dental amalgam usage."